Investor Update
Basel, 7 October 2005
Roche becomes founding member of ICRC Corporate Support Group
Novel partnership between the International Committee of the Red Cross and the business world
Roche has joined with several other companies in forging a strategic, long-term partnership with the International Committee of the Red Cross (ICRC). Jakob Kellenberger, President of ICRC, and representatives of the companies gathered today in Geneva to launch the ICRC Corporate Support Group, ushering in an innovative new form of partnership with the ICRC. This partnership is committed to supporting the humanitarian mission of the ICRC.
Under the terms of the partnership, Roche will provide significant support to the ICRC over a six-year period starting this year. This support will include cash donations as well as in-kind donations of goods and services. The ICRC will allocate the resources it receives from Roche to humanitarian programmes in emergency situations or use them for rehabilitation purposes in the aftermath of conflicts and major disasters. Additionally, the ICRC may use Roche’s donations for prevention efforts in areas where an emergency appears likely to occur. Roche will consider the ICRC its primary global partner for channelling resources to support humanitarian efforts in emergency situations.
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics, the leading supplier of drugs for cancer and transplantation and a market leader in virology. In 2004 sales by the Pharmaceuticals Division totalled 21.7 billion Swiss francs, while the Diagnostics Division posted sales of 7.8 billion Swiss francs. Roche employs roughly 65,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet at www.roche.com. Roche has a long history of active community involvement. In addition to humanitarian projects, Roche promotes research, the professional development of young scientists and the arts. The company also encourages its employees to get involved in their local communities.
Further information
- International Committee of the Red Cross
- Roche & Sustainable Development
Roche becomes founding member of ICRC Corporate Support Group
Novel partnership between the International Committee of the Red Cross and the business world
Roche has joined with several other companies in forging a strategic, long-term partnership with the International Committee of the Red Cross (ICRC). Jakob Kellenberger, President of ICRC, and representatives of the companies gathered today in Geneva to launch the ICRC Corporate Support Group, ushering in an innovative new form of partnership with the ICRC. This partnership is committed to supporting the humanitarian mission of the ICRC.
Under the terms of the partnership, Roche will provide significant support to the ICRC over a six-year period starting this year. This support will include cash donations as well as in-kind donations of goods and services. The ICRC will allocate the resources it receives from Roche to humanitarian programmes in emergency situations or use them for rehabilitation purposes in the aftermath of conflicts and major disasters. Additionally, the ICRC may use Roche’s donations for prevention efforts in areas where an emergency appears likely to occur. Roche will consider the ICRC its primary global partner for channelling resources to support humanitarian efforts in emergency situations.
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics, the leading supplier of drugs for cancer and transplantation and a market leader in virology. In 2004 sales by the Pharmaceuticals Division totalled 21.7 billion Swiss francs, while the Diagnostics Division posted sales of 7.8 billion Swiss francs. Roche employs roughly 65,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet at www.roche.com. Roche has a long history of active community involvement. In addition to humanitarian projects, Roche promotes research, the professional development of young scientists and the arts. The company also encourages its employees to get involved in their local communities.
All trademarks used or mentioned in this release are protected by law.
Further information
- International Committee of the Red Cross
- Roche & Sustainable Development